# Brunswick Corp: financial statements, quarterly

BC · NYSE · CIK 14930 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bc.md) · [Financials](/companies/bc/financials.md) · [Filings](/companies/bc/filings.md) · [Insiders](/companies/bc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,594](/filings/0000014930-24-000157.md) | [1,362 d](/filings/0000014930-26-000027.md) | [1,365](/filings/0000014930-25-000053.md) | [1,444](/filings/0000014930-25-000092.md) | [1,273](/filings/0000014930-25-000125.md) | [1,155 d](/filings/0000014930-26-000027.md) | [1,222](/filings/0000014930-26-000070.md) | [1,447](/filings/0000014930-26-000110.md) | [1,360](/filings/0000014930-25-000125.md) | [1,334 d](/filings/0000014930-26-000027.md) | [1,378](/filings/0000014930-26-000070.md) | [1,558](/filings/0000014930-26-000110.md) |
| Cost of revenue | $m | [1,149](/filings/0000014930-24-000157.md) | [998 d](/filings/0000014930-26-000027.md) | [991](/filings/0000014930-25-000053.md) | [1,053](/filings/0000014930-25-000092.md) | [940](/filings/0000014930-25-000125.md) | [902 d](/filings/0000014930-26-000027.md) | [918](/filings/0000014930-26-000070.md) | [1,077](/filings/0000014930-26-000110.md) | [1,009](/filings/0000014930-25-000125.md) | [1,026 d](/filings/0000014930-26-000027.md) | [1,035](/filings/0000014930-26-000070.md) | [1,120](/filings/0000014930-26-000110.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [45.2](/filings/0000014930-24-000157.md) | [42.4 d](/filings/0000014930-26-000027.md) | [45.8](/filings/0000014930-25-000053.md) | [43.0](/filings/0000014930-25-000092.md) | [41.7](/filings/0000014930-25-000125.md) | [39.1 d](/filings/0000014930-26-000027.md) | [38.5](/filings/0000014930-26-000070.md) | [41.8](/filings/0000014930-26-000110.md) | [43.4](/filings/0000014930-25-000125.md) | [45.0 d](/filings/0000014930-26-000027.md) | [46.3](/filings/0000014930-26-000070.md) | [50.4](/filings/0000014930-26-000110.md) |
| Selling, general and administrative | $m | [187](/filings/0000014930-24-000157.md) | [199 d](/filings/0000014930-26-000027.md) | [204](/filings/0000014930-25-000053.md) | [182](/filings/0000014930-25-000092.md) | [181](/filings/0000014930-25-000125.md) | [182 d](/filings/0000014930-26-000027.md) | [208](/filings/0000014930-26-000070.md) | [217](/filings/0000014930-26-000110.md) | [216](/filings/0000014930-25-000125.md) | [211 d](/filings/0000014930-26-000027.md) | [242](/filings/0000014930-26-000070.md) | [251](/filings/0000014930-26-000110.md) |
| Operating income | $m | [196](/filings/0000014930-24-000157.md) | [108 d](/filings/0000014930-26-000027.md) | [111](/filings/0000014930-25-000053.md) | [158](/filings/0000014930-25-000092.md) | [98.4](/filings/0000014930-25-000125.md) | [(55.7) d](/filings/0000014930-26-000027.md) | [56.3](/filings/0000014930-26-000070.md) | [103](/filings/0000014930-26-000110.md) | [(242)](/filings/0000014930-25-000125.md) | [41.9 d](/filings/0000014930-26-000027.md) | [50.3](/filings/0000014930-26-000070.md) | [129](/filings/0000014930-26-000110.md) |
| Interest expense | $m | [28.1](/filings/0000014930-24-000157.md) | [27.3 d](/filings/0000014930-26-000027.md) | [28.6](/filings/0000014930-25-000053.md) | [32.6](/filings/0000014930-25-000092.md) | [33.0](/filings/0000014930-25-000125.md) | [32.4 d](/filings/0000014930-26-000027.md) | [29.7](/filings/0000014930-26-000070.md) | [30.0](/filings/0000014930-26-000110.md) | [27.0](/filings/0000014930-25-000125.md) | [25.0 d](/filings/0000014930-26-000027.md) | [24.6](/filings/0000014930-26-000070.md) | [24.8](/filings/0000014930-26-000110.md) |
| Income tax | $m | [46.2](/filings/0000014930-24-000157.md) | [14.8 d](/filings/0000014930-26-000027.md) | [18.6](/filings/0000014930-25-000053.md) | [27.7](/filings/0000014930-25-000092.md) | [22.6](/filings/0000014930-25-000125.md) | [(14.9) d](/filings/0000014930-26-000027.md) | [7.9](/filings/0000014930-26-000070.md) | [15.7](/filings/0000014930-26-000110.md) | [(32.0)](/filings/0000014930-25-000125.md) | [8.6 d](/filings/0000014930-26-000027.md) | [5.9](/filings/0000014930-26-000070.md) | [(1.8)](/filings/0000014930-26-000110.md) |
| Net income | $m | [113](/filings/0000014930-24-000157.md) | [60.9 d](/filings/0000014930-26-000027.md) | [68.0](/filings/0000014930-25-000125.md) | [100](/filings/0000014930-25-000125.md) | [44.6](/filings/0000014930-25-000125.md) | [(82.5) d](/filings/0000014930-26-000027.md) | [20.2](/filings/0000014930-26-000110.md) | [59.3](/filings/0000014930-26-000110.md) | [(236)](/filings/0000014930-25-000125.md) | [18.7 d](/filings/0000014930-26-000027.md) | [21.0](/filings/0000014930-26-000110.md) | [110](/filings/0000014930-26-000110.md) |
| Diluted EPS | $ per share | [1.61](/filings/0000014930-24-000157.md) | not reported | [0.99](/filings/0000014930-25-000053.md) | [1.48](/filings/0000014930-25-000092.md) | [0.67](/filings/0000014930-25-000125.md) | not reported | [0.30](/filings/0000014930-26-000070.md) | [0.89](/filings/0000014930-26-000110.md) | [(3.59)](/filings/0000014930-25-000125.md) | not reported | [0.32](/filings/0000014930-26-000070.md) | [1.68](/filings/0000014930-26-000110.md) |
| Basic EPS | $ per share | [1.61](/filings/0000014930-24-000157.md) | not reported | [0.99](/filings/0000014930-25-000053.md) | [1.48](/filings/0000014930-25-000092.md) | [0.67](/filings/0000014930-25-000125.md) | not reported | [0.31](/filings/0000014930-26-000070.md) | [0.89](/filings/0000014930-26-000110.md) | [(3.59)](/filings/0000014930-25-000125.md) | not reported | [0.32](/filings/0000014930-26-000070.md) | [1.68](/filings/0000014930-26-000110.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [331](/filings/0000014930-24-000157.md) | [468](/filings/0000014930-26-000027.md) | [495](/filings/0000014930-25-000092.md) | [495](/filings/0000014930-25-000092.md) | [284](/filings/0000014930-25-000125.md) | [269](/filings/0000014930-26-000027.md) | [287](/filings/0000014930-26-000070.md) | [316](/filings/0000014930-26-000110.md) | [298](/filings/0000014930-25-000125.md) | [257](/filings/0000014930-26-000110.md) | [278](/filings/0000014930-26-000070.md) | [288](/filings/0000014930-26-000110.md) |
| Current assets | $m | [2,441](/filings/0000014930-24-000157.md) | [2,510](/filings/0000014930-25-000025.md) | [2,807](/filings/0000014930-25-000053.md) | [2,728](/filings/0000014930-25-000092.md) | [2,348](/filings/0000014930-25-000125.md) | [2,114](/filings/0000014930-26-000027.md) | [2,306](/filings/0000014930-26-000070.md) | [2,236](/filings/0000014930-26-000110.md) | [2,158](/filings/0000014930-25-000125.md) | [2,063](/filings/0000014930-26-000110.md) | [2,286](/filings/0000014930-26-000070.md) | [2,207](/filings/0000014930-26-000110.md) |
| Total assets | $m | [6,101](/filings/0000014930-24-000157.md) | [6,231](/filings/0000014930-25-000025.md) | [6,509](/filings/0000014930-25-000053.md) | [6,396](/filings/0000014930-25-000092.md) | [6,024](/filings/0000014930-25-000125.md) | [5,678](/filings/0000014930-26-000027.md) | [5,857](/filings/0000014930-26-000070.md) | [5,794](/filings/0000014930-26-000110.md) | [5,414](/filings/0000014930-25-000125.md) | [5,312](/filings/0000014930-26-000110.md) | [5,506](/filings/0000014930-26-000070.md) | [5,505](/filings/0000014930-26-000110.md) |
| Current liabilities | $m | [1,659](/filings/0000014930-24-000157.md) | [1,752](/filings/0000014930-25-000025.md) | [1,674](/filings/0000014930-25-000053.md) | [1,608](/filings/0000014930-25-000092.md) | [1,194](/filings/0000014930-25-000125.md) | [1,280](/filings/0000014930-26-000027.md) | [1,468](/filings/0000014930-26-000070.md) | [1,334](/filings/0000014930-26-000110.md) | [1,215](/filings/0000014930-25-000125.md) | [1,429](/filings/0000014930-26-000110.md) | [1,662](/filings/0000014930-26-000070.md) | [1,525](/filings/0000014930-26-000110.md) |
| Long-term debt | $m | [1,976](/filings/0000014930-24-000157.md) | [1,976](/filings/0000014930-25-000025.md) | [2,372](/filings/0000014930-25-000053.md) | [2,372](/filings/0000014930-25-000092.md) | [2,373](/filings/0000014930-25-000125.md) | [2,098](/filings/0000014930-26-000027.md) | [2,098](/filings/0000014930-26-000070.md) | [2,098](/filings/0000014930-26-000110.md) | [2,097](/filings/0000014930-25-000125.md) | [1,807](/filings/0000014930-26-000110.md) | [1,806](/filings/0000014930-26-000070.md) | [1,806](/filings/0000014930-26-000110.md) |
| Current portion of debt | $m | [455](/filings/0000014930-23-000182.md) | [455](/filings/0000014930-25-000025.md) | [455](/filings/0000014930-24-000103.md) | [455](/filings/0000014930-24-000126.md) | [199](/filings/0000014930-24-000157.md) | [243](/filings/0000014930-26-000027.md) | [386](/filings/0000014930-25-000053.md) | [177](/filings/0000014930-25-000092.md) | [95.8](/filings/0000014930-25-000125.md) | [295](/filings/0000014930-26-000110.md) | [490](/filings/0000014930-26-000070.md) | [295](/filings/0000014930-26-000110.md) |
| Short-term borrowings | $m | not reported | [0.0](/filings/0000014930-25-000025.md) | not reported | not reported | [195](/filings/0000014930-25-000125.md) | [115](/filings/0000014930-26-000027.md) | [380](/filings/0000014930-26-000070.md) | [170](/filings/0000014930-26-000110.md) | [90.0](/filings/0000014930-25-000125.md) | [290](/filings/0000014930-26-000027.md) | [485](/filings/0000014930-26-000070.md) | [290](/filings/0000014930-26-000110.md) |
| Shareholders' equity | $m | [2,086](/filings/0000014930-24-000157.md) | [2,087](/filings/0000014930-26-000027.md) | [2,050](/filings/0000014930-25-000125.md) | [2,014](/filings/0000014930-25-000125.md) | [2,034](/filings/0000014930-25-000125.md) | [1,892](/filings/0000014930-26-000110.md) | [1,872](/filings/0000014930-26-000110.md) | [1,905](/filings/0000014930-26-000110.md) | [1,634](/filings/0000014930-25-000125.md) | [1,626](/filings/0000014930-26-000110.md) | [1,602](/filings/0000014930-26-000110.md) | [1,679](/filings/0000014930-26-000110.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [198 d](/filings/0000014930-24-000157.md) | [283 d](/filings/0000014930-26-000027.md) | [(153)](/filings/0000014930-25-000053.md) | [211 d](/filings/0000014930-25-000092.md) | [67.4 d](/filings/0000014930-25-000125.md) | [306 d](/filings/0000014930-26-000027.md) | [(27.4)](/filings/0000014930-26-000070.md) | [316 d](/filings/0000014930-26-000110.md) | [140 d](/filings/0000014930-25-000125.md) | [133 d](/filings/0000014930-26-000027.md) | [(64.1)](/filings/0000014930-26-000070.md) | [314 d](/filings/0000014930-26-000110.md) |
| Capital expenditure | $m | [59.7 d](/filings/0000014930-24-000157.md) | [56.2 d](/filings/0000014930-26-000027.md) | [54.0](/filings/0000014930-25-000053.md) | [47.1](/filings/0000014930-25-000092.md) | [36.0](/filings/0000014930-25-000125.md) | [30.3 d](/filings/0000014930-26-000027.md) | [37.7](/filings/0000014930-26-000070.md) | [44.9](/filings/0000014930-26-000110.md) | [33.9](/filings/0000014930-25-000125.md) | [49.3 d](/filings/0000014930-26-000027.md) | [57.2](/filings/0000014930-26-000070.md) | [41.4](/filings/0000014930-26-000110.md) |
| Dividends paid | $m | [27.8 d](/filings/0000014930-24-000157.md) | [27.4 d](/filings/0000014930-26-000027.md) | [28.6](/filings/0000014930-25-000053.md) | [28.2 d](/filings/0000014930-25-000092.md) | [27.8 d](/filings/0000014930-25-000125.md) | [27.7 d](/filings/0000014930-26-000027.md) | [28.2](/filings/0000014930-26-000070.md) | [28.4 d](/filings/0000014930-26-000110.md) | [28.0 d](/filings/0000014930-25-000125.md) | [28.0 d](/filings/0000014930-26-000027.md) | [28.7](/filings/0000014930-26-000070.md) | [28.5 d](/filings/0000014930-26-000110.md) |
| Share repurchases | $m | [87.8 d](/filings/0000014930-24-000157.md) | [55.0 d](/filings/0000014930-26-000027.md) | [63.6](/filings/0000014930-25-000053.md) | [106 d](/filings/0000014930-25-000092.md) | [20.0 d](/filings/0000014930-25-000125.md) | [10.0 d](/filings/0000014930-26-000027.md) | [25.6](/filings/0000014930-26-000070.md) | [17.5 d](/filings/0000014930-26-000110.md) | [21.9 d](/filings/0000014930-25-000125.md) | [15.0 d](/filings/0000014930-26-000027.md) | [16.2](/filings/0000014930-26-000070.md) | [15.0 d](/filings/0000014930-26-000110.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [74.5](/filings/0000014930-23-000182.md) | [71.8](/filings/0000014930-24-000103.md) | [70.9](/filings/0000014930-24-000126.md) | [70.0](/filings/0000014930-24-000157.md) | [68.5](/filings/0000014930-25-000053.md) | [67.6](/filings/0000014930-25-000092.md) | [66.6](/filings/0000014930-25-000125.md) | [66.3](/filings/0000014930-26-000070.md) | [66.0](/filings/0000014930-26-000110.md) | [65.7](/filings/0000014930-25-000125.md) | [65.7](/filings/0000014930-26-000070.md) | [65.5](/filings/0000014930-26-000110.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 64,797,428 at 2026-07-30, from the cover of the [10-Q filed 2026-08-05](/filings/0000014930-26-000110.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.